130 related articles for article (PubMed ID: 15250292)
1. [Prostaglandin/bradykinin].
Hirawa N; Umemura S
Nihon Rinsho; 2004 Jun; 62 Suppl 6():183-8. PubMed ID: 15250292
[No Abstract] [Full Text] [Related]
2. [Effects of NSAIDs on prostaglandin synthesis].
Watanabe T; Higuchi K; Tominaga K; Uchida T; Fujiwara Y; Arakawa T
Nihon Rinsho; 2002 Feb; 60 Suppl 2():190-4. PubMed ID: 11979776
[No Abstract] [Full Text] [Related]
3. [COX-2].
Oh-ishi S
Tanpakushitsu Kakusan Koso; 2000 Apr; 45(6 Suppl):1109-13. PubMed ID: 10771681
[No Abstract] [Full Text] [Related]
4. The role of cyclooxygenase-2 in the pathogenesis of skin cancer.
Brecher AR
J Drugs Dermatol; 2002 Jul; 1(1):44-7. PubMed ID: 12847753
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandins and renal damage.
Navarro JF
J Am Soc Nephrol; 1996 Aug; 7(8):1245-6. PubMed ID: 8866420
[No Abstract] [Full Text] [Related]
6. [Physiopathological and therapeutic study of collagen diseases based on results of clinical tests--role of prostaglandins].
Sano H
Nihon Naika Gakkai Zasshi; 1998 Dec; 87(12):2438-45. PubMed ID: 9922664
[No Abstract] [Full Text] [Related]
7. The discovery and function of COX-2.
Needleman P; Isakson PC
J Rheumatol Suppl; 1997 Jul; 49():6-8. PubMed ID: 9249644
[No Abstract] [Full Text] [Related]
8. COX-2: a target for prevention and treatment of esophageal cancer.
Altorki N
J Surg Res; 2004 Mar; 117(1):114-20. PubMed ID: 15013721
[No Abstract] [Full Text] [Related]
9. [Prostanoids and acute lung injury].
Kudoh I; Ohara M; Sawa T
Masui; 2002 Jun; 51(6):598-604. PubMed ID: 12134647
[TBL] [Abstract][Full Text] [Related]
10. [Significance of COX-2].
Tatsuguchi A; Sakamoto C
Nihon Rinsho; 2002 Feb; 60 Suppl 2():207-10. PubMed ID: 11979779
[No Abstract] [Full Text] [Related]
11. [Is it safe and efficient to use nonsteroidal anti-inflammatory agent by selective reduction of prostaglandin production?].
Kankaanranta H; Vapaatalo H
Duodecim; 1996; 112(5):419-24. PubMed ID: 10592604
[No Abstract] [Full Text] [Related]
12. [Pharmacological bases of non-steroidal anti-inflammatory analgesics].
Beltrán B; Moreno L; Esplugues JV
Gastroenterol Hepatol; 1996 Nov; 19(9):478-88. PubMed ID: 8998674
[No Abstract] [Full Text] [Related]
13. [COX-2 expression in gastric cancers].
Sakamoto C
Nihon Rinsho; 2001 Apr; 59 Suppl 4():598-603. PubMed ID: 11424449
[No Abstract] [Full Text] [Related]
14. Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2.
Gupta RA; Dubois RN
Nat Rev Cancer; 2001 Oct; 1(1):11-21. PubMed ID: 11900248
[TBL] [Abstract][Full Text] [Related]
15. Cyclooxygenase-2 (COX-2) enzyme inhibitors and radiotherapy: preclinical basis.
Milas L
Am J Clin Oncol; 2003 Aug; 26(4):S66-9. PubMed ID: 12902859
[TBL] [Abstract][Full Text] [Related]
16. [Colorectal cancer and inhibition of cyclooxygenase-2].
Geissler M; Mohr L; Blum HE
Dtsch Med Wochenschr; 2002 Jun; 127(23):1256-8. PubMed ID: 12053285
[No Abstract] [Full Text] [Related]
17. [Cyclooxygenase-2 (COX-2) in digestive cancer. Therapeutic implications].
Bessa X; Piñol V; Elizalde JI; Castells A
Gastroenterol Hepatol; 2000 Dec; 23(10):483-90. PubMed ID: 11149225
[No Abstract] [Full Text] [Related]
18. Selective cyclooxygenase-2 inhibition: biological and clinical effects.
Conti F; Spinelli FR; Ossandon A; Valesini G
Isr Med Assoc J; 2000 Nov; 2(11):841-7. PubMed ID: 11344755
[No Abstract] [Full Text] [Related]
19. [Current topics in the regulation of prostanoids-1. Inducible cyclooxygenase COX-2 and selective blockers].
Ohara M; Sawa T
Masui; 1998 Nov; 47(11):1325-32. PubMed ID: 9852696
[TBL] [Abstract][Full Text] [Related]
20. COX-2 inhibitors--is there cause for concern?
Seibert K; Lefkowith J; Tripp C; Isakson P; Needleman P
Nat Med; 1999 Jun; 5(6):621-2. PubMed ID: 10371498
[No Abstract] [Full Text] [Related]
[Next] [New Search]
